Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study

被引:3
|
作者
Tanaka, Shogo [1 ]
Noda, Takehiro [2 ]
Komeda, Koji [3 ]
Kosaka, Hisashi [4 ]
Iida, Hiroya [5 ]
Ueno, Masaki [6 ]
Hokuto, Daisuke [7 ]
Ikoma, Hisashi [8 ]
Nakai, Takuya [9 ]
Kabata, Daijiro [10 ]
Shinkawa, Hiroji [1 ]
Kobayashi, Shogo [2 ]
Hirokawa, Fumitoshi [3 ]
Mori, Haruki [5 ]
Hayami, Shinya [6 ]
Morimura, Ryo [7 ]
Matsumoto, Masataka [8 ]
Ishizawa, Takeaki [1 ]
Kubo, Shoji [1 ]
Kaibori, Masaki [4 ]
机构
[1] Osaka Metropolitan Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, 1-4-3 Asahimachi, Abeno Ku, Osaka 5458585, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan
[3] Osaka Med & Pharmaceut Univ, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka, Japan
[4] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan
[5] Shiga Univ Med Sci, Dept Surg, Div Gastrointestinal Breast & Gen Surg, Otsu, Japan
[6] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan
[7] Nara Med Univ, Dept Surg, Kashihara, Nara, Japan
[8] Kyoto Prefectural Univ Med, Dept Surg, Kyoto, Japan
[9] Kindai Univ, Fac Med, Dept Surg, Osaka, Osaka, Japan
[10] Osaka Metropolitan Univ, Dept Med Stat, Grad Sch Med, Osaka, Japan
关键词
AFP; ALBI grade; Hepatocellular carcinoma; Operation time; LAPAROSCOPIC LIVER RESECTION; C VIRUS-INFECTION; HEPATIC RESECTION; INTRAHEPATIC RECURRENCE; CIRRHOTIC-PATIENTS; ALBUMIN-BILIRUBIN; SCORING SYSTEM; RISK-FACTORS; ALBI GRADE; SURVIVAL;
D O I
10.1007/s11605-022-05549-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundsLiver resection for hepatocellular carcinoma (HCC) in patients with Child-Pugh class (CPC) B increases the incidence of postoperative complication and in-hospital death and decreases the disease-free survival (DFS) and overall survival (OS) compared with those with CPC A. Conversely, some selected patients possibly gained benefits for liver resection. MethodsClinical records of 114 patients with CPC B who underwent liver resection for HCC were retrospectively reviewed. The risk of postoperative complications (Clavien-Dindo classification grade of & GE; II), postoperative recurrence, and death was analyzed. ResultsPostoperative complications occurred in 36 patients (31.6%), and 2 died within 90 days postoperatively due to the liver and respiratory failure, respectively. Multivariate analysis indicated that albumin-bilirubin (ALB) grade III and extended operation time were found as independent risk factors for postoperative complications. The DFS and OS rates at 3/5 years after liver resection were 30.8%/25.3% and 68.4%/48.9%, respectively. Multivariate analysis indicated that the extended blood loss, high alpha-fetoprotein (AFP) level (& GE; 200 ng/mL), and Barcelona Clinic Liver Cancer stage C were found to be independent risk factors for postoperative recurrence. The high AFP level was also an independent prognostic factor for OS. Patients with high AFP levels had postoperative recurrence within 2 years and a higher number of extrahepatic recurrences than those with low AFP levels (< 200 ng/mL). ConclusionFor patients with HCC with CPC B who were scheduled for liver resection, ALBI grade III and high AFP level should be considered as unfavorable outcomes after liver resection.
引用
收藏
页码:283 / 295
页数:13
相关论文
共 50 条
  • [1] Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child–Pugh Class B: a Retrospective Multicenter Study
    Shogo Tanaka
    Takehiro Noda
    Koji Komeda
    Hisashi Kosaka
    Hiroya Iida
    Masaki Ueno
    Daisuke Hokuto
    Hisashi Ikoma
    Takuya Nakai
    Daijiro Kabata
    Hiroji Shinkawa
    Shogo Kobayashi
    Fumitoshi Hirokawa
    Haruki Mori
    Shinya Hayami
    Ryo Morimura
    Masataka Matsumoto
    Takeaki Ishizawa
    Shoji Kubo
    Masaki Kaibori
    Journal of Gastrointestinal Surgery, 2023, 27 : 283 - 295
  • [2] Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study
    Kim, Hyung-Don
    Bang, Yeonghak
    Lee, Myung Ah
    Kim, Jin Won
    Kim, Jee Hyun
    Chon, Hong Jae
    Kang, Beodeul
    Kang, Myoung Joo
    Kim, Ilhwan
    Cheon, Jaekyung
    Hwang, Jun-Eul
    Kang, Jung Hun
    Byeon, Seonggyu
    Hong, Jung Yong
    Ryoo, Baek-Yeol
    Lim, Ho Yeong
    Yoo, Changhoon
    LIVER INTERNATIONAL, 2020, 40 (10) : 2544 - 2552
  • [3] Nivolumab plus ipilimumab in advanced hepatocellular carcinoma with Child-Pugh B: A multicenter retrospective study.
    Kim, Jung Sun
    Kim, Youngun
    Kim, Hyeyeong
    Kang, Beodeul
    An, Chansik
    Kim, Ilhwan
    Kim, Chan
    Chon, Hong Jae
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 551 - 551
  • [4] Treatment of hepatocellular carcinoma in Child-Pugh B patients
    Piscaglia, Fabio
    Terzi, Eleonora
    Cucchetti, Alessandro
    Trimarchi, Chiara
    Granito, Alessandro
    Leoni, Simona
    Marinelli, Sara
    Pini, Patrizia
    Bolondi, Luigi
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (10) : 852 - 858
  • [5] Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series
    Kambhampati, Swetha
    Bauer, Kelly E.
    Bracci, Paige M.
    Keenan, Bridget P.
    Behr, Spencer C.
    Gordan, John D.
    Kelley, Robin K.
    CANCER, 2019, 125 (18) : 3234 - 3241
  • [6] Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis
    Diamond, Brett H.
    Banson, Kara
    Ayash, Jonathan
    Lee, Peter
    Shukla, Utkarsh C.
    Jones, Gavin
    Rava, Paul
    Fitzgerald, Thomas J.
    Sioshansi, Shirin
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (12)
  • [7] Stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma with Child-Pugh class B
    Cardenes, Higinia Rosa
    Lasley, Foster D.
    Kwo, Paul
    Perkins, Susan M.
    Maluccio, Mary A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B
    Kuroda, Shintaro
    Tashiro, Hirotaka
    Kobayashi, Tsuyoshi
    Oshita, Akihiko
    Amano, Hironobu
    Ohdan, Hideki
    WORLD JOURNAL OF SURGERY, 2011, 35 (04) : 834 - 841
  • [9] Indication of Hepatectomy for Cirrhotic Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B
    Hideki Nakahara
    Toshiyuki Itamoto
    Koji Katayama
    Hideki Ohdan
    Hiroshi Hino
    Makoto Ochi
    Hirotaka Tashiro
    Toshimasa Asahara
    World Journal of Surgery, 2005, 29 : 734 - 738
  • [10] Systemic therapy for Child-Pugh B patients with hepatocellular carcinoma
    Mok, Kevin
    Chen, Olivia
    Yau, Johnny
    Chan, Landon L.
    Chan, Stephen L.
    EXPERT OPINION ON EMERGING DRUGS, 2025, 30 (01) : 1 - 5